Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis

Abstract Background 99mTc-labelled bisphosphonates are used for imaging assessment of patients with transthyretin cardiac amyloidosis (ATTR). Present study evaluates whether quantitative SPECT/CT measurement of absolute myocardial 99mTc-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid (Tc-DPD)...

Full description

Bibliographic Details
Main Authors: Simona Ben-Haim, A. Chicheportiche, E. Goshen, M. Arad, M. Smekhov, L. J. Menezes, P. M. Elliott, E. O’Mahoney, E. Stern, Bella Yuzefovich, J. B. Bomanji
Format: Article
Language:English
Published: SpringerOpen 2021-09-01
Series:EJNMMI Research
Subjects:
Online Access:https://doi.org/10.1186/s13550-021-00828-0
id doaj-fc45544c7d9840f79c5f6d73a1c02a2a
record_format Article
spelling doaj-fc45544c7d9840f79c5f6d73a1c02a2a2021-09-12T11:17:52ZengSpringerOpenEJNMMI Research2191-219X2021-09-0111111010.1186/s13550-021-00828-0Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosisSimona Ben-Haim0A. Chicheportiche1E. Goshen2M. Arad3M. Smekhov4L. J. Menezes5P. M. Elliott6E. O’Mahoney7E. Stern8Bella Yuzefovich9J. B. Bomanji10Hadassah Medical Center, Hebrew UniversityHadassah Medical Center, Hebrew UniversityWolfson Medical Center, Sackler School of Medicine, Tel Aviv UniversityChaim Sheba Medical CenterChaim Sheba Medical CenterNIHR Biomedical Research Centre, UCL Institute of Nuclear MedicineNIHR Biomedical Research Centre, UCL Institute of Nuclear MedicineNIHR Biomedical Research Centre, UCL Institute of Nuclear MedicineGE HealthcareGE HealthcareNIHR Biomedical Research Centre, UCL Institute of Nuclear MedicineAbstract Background 99mTc-labelled bisphosphonates are used for imaging assessment of patients with transthyretin cardiac amyloidosis (ATTR). Present study evaluates whether quantitative SPECT/CT measurement of absolute myocardial 99mTc-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid (Tc-DPD) uptake can diagnose patients with suspected ATTR. Methods Twenty-eight patients (25 male, age 80.03 ± 6.99 years) with suspected ATTR referred for Tc-DPD imaging had planar and SPECT/CT imaging of the chest. Three operators independently obtained Tc-DPD myocardial SUVmax and SUVmean above threshold (SMaT) (20, 40 and 60% of SUVmax), using a semi-automated threshold segmentation method. Results were compared to visual grading (0–3) of cardiac uptake. Results Twenty-two patients (78%) had cardiac uptake (2 grade 1, 15 grade 2, 5 grade 3). SUVmax and SMaT segmentation thresholds enabled separating grades 2/3 from 0/1 with excellent inter- and intra-reader correlation. Cut-off values 6.0, 2.5, 3 and 4 for SUVmax, SMaT20,40,60, respectively, separated between grades 2/3 and 0 /1 with PPV and NPV of 100%. SMaT20,40,60(cardiac)/SUVmean (liver) and SMaT20,40,60(cardiac)/SUVmean(liver/lung) separated grades 2 and 3. Conclusion Quantitative SPECT/CT parameters of cardiac Tc-DPD uptake are robust, enabling separation of patients with grades 2 and 3 cardiac uptake from grades 0 and 1. Larger patient cohorts will determine the incremental value of SPECT/CT quantification for ATTR management.https://doi.org/10.1186/s13550-021-00828-0Amyloid heart diseaseSPECTImage analysisSPECT/CT quantitation
collection DOAJ
language English
format Article
sources DOAJ
author Simona Ben-Haim
A. Chicheportiche
E. Goshen
M. Arad
M. Smekhov
L. J. Menezes
P. M. Elliott
E. O’Mahoney
E. Stern
Bella Yuzefovich
J. B. Bomanji
spellingShingle Simona Ben-Haim
A. Chicheportiche
E. Goshen
M. Arad
M. Smekhov
L. J. Menezes
P. M. Elliott
E. O’Mahoney
E. Stern
Bella Yuzefovich
J. B. Bomanji
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
EJNMMI Research
Amyloid heart disease
SPECT
Image analysis
SPECT/CT quantitation
author_facet Simona Ben-Haim
A. Chicheportiche
E. Goshen
M. Arad
M. Smekhov
L. J. Menezes
P. M. Elliott
E. O’Mahoney
E. Stern
Bella Yuzefovich
J. B. Bomanji
author_sort Simona Ben-Haim
title Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
title_short Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
title_full Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
title_fullStr Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
title_full_unstemmed Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
title_sort quantitative spect/ct parameters of myocardial 99mtechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (dpd) uptake in suspected cardiac transthyretin amyloidosis
publisher SpringerOpen
series EJNMMI Research
issn 2191-219X
publishDate 2021-09-01
description Abstract Background 99mTc-labelled bisphosphonates are used for imaging assessment of patients with transthyretin cardiac amyloidosis (ATTR). Present study evaluates whether quantitative SPECT/CT measurement of absolute myocardial 99mTc-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid (Tc-DPD) uptake can diagnose patients with suspected ATTR. Methods Twenty-eight patients (25 male, age 80.03 ± 6.99 years) with suspected ATTR referred for Tc-DPD imaging had planar and SPECT/CT imaging of the chest. Three operators independently obtained Tc-DPD myocardial SUVmax and SUVmean above threshold (SMaT) (20, 40 and 60% of SUVmax), using a semi-automated threshold segmentation method. Results were compared to visual grading (0–3) of cardiac uptake. Results Twenty-two patients (78%) had cardiac uptake (2 grade 1, 15 grade 2, 5 grade 3). SUVmax and SMaT segmentation thresholds enabled separating grades 2/3 from 0/1 with excellent inter- and intra-reader correlation. Cut-off values 6.0, 2.5, 3 and 4 for SUVmax, SMaT20,40,60, respectively, separated between grades 2/3 and 0 /1 with PPV and NPV of 100%. SMaT20,40,60(cardiac)/SUVmean (liver) and SMaT20,40,60(cardiac)/SUVmean(liver/lung) separated grades 2 and 3. Conclusion Quantitative SPECT/CT parameters of cardiac Tc-DPD uptake are robust, enabling separation of patients with grades 2 and 3 cardiac uptake from grades 0 and 1. Larger patient cohorts will determine the incremental value of SPECT/CT quantification for ATTR management.
topic Amyloid heart disease
SPECT
Image analysis
SPECT/CT quantitation
url https://doi.org/10.1186/s13550-021-00828-0
work_keys_str_mv AT simonabenhaim quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT achicheportiche quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT egoshen quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT marad quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT msmekhov quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT ljmenezes quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT pmelliott quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT eomahoney quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT estern quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT bellayuzefovich quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
AT jbbomanji quantitativespectctparametersofmyocardial99mtechnetium33diphosphono12propanodicarboxylicaciddpduptakeinsuspectedcardiactransthyretinamyloidosis
_version_ 1717755884731367424